EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Early COVID-19 and protection from Omicron in a highly vaccinated population in Ontario, Canada: a matched prospective cohort study

Altynay Shigayeva, Christopher Kandel, Lubna Farooqi, Zoe Zhong, Anne-Claude Gingras, Brenda L Coleman, Lois Gilbert, Wayne L Gold, Maria Major, Tony Mazzulli, Samira Mubareka, Jelena Vojicic und 6 weitere

BMC Infectious Diseases · 2025

DOI: 10.1186/s12879-024-10331-1 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift BMC Infectious Diseases, 2025. Verfasst von Altynay Shigayeva und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Sinai Health, Toronto, Canada. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Vaccines. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Predictions regarding the on-going burden of SARS-CoV-2, and vaccine recommendations, require an understanding of infection-associated immune protection. We assessed whether early COVID-19 provided protection against Omicron infection.

Methods

We enrolled a cohort of adults in Ontario, Canada, with COVID-19 prior to October 2020 (early infection, EI), and a matched cohort with COVID-19 testing and a negative PCR (non-EI). Participants completed baseline surveys then surveys every two weeks until January 2023. Multivariable Cox regression was used to assess factors associated with COVID-19 infection during the first 14 months of Omicron.

Results

Overall, 624 EI (70%) and 175 (77%) non-EI participants met criteria for analysis; 590 (95%) EI and 164 (94%) non-EI had received at least 2 COVID-19 vaccine doses prior to Omicron. Of 624 EI, 175 (28%) had one SARS-CoV-2 re-infection and 8 (1.3%) had two, compared to 84 (48%) non-EI participants with one, 5 (2.9%) with two and 1 (0.6%) with 3 infections ( P < 0.0001). In multivariable analysis of risk factors for Omicron infection, the overall hazard ratio (HR, 95%CI) associated with EI was 0.56 (0.43–0.74); HRs for BA.1/2, BA.4/5 and mixed BA.5/BQ.1/XBB periods were 0.66 (0.45–0.97), 0.44 (0.28–0.68) and 0.71 (0.32–1.56). EI and BA.1/2 infection combined reduced later Omicron infection (HR 0.07 (0.03–0.21) compared to no prior infection. Older age, non-White ethnicity, no children in household, and lower neighbourhood income were associated with reduced risk of infection.

Conclusions

In our highly vaccinated population, early SARS-CoV-2 infection was associated with a 44% reduction in symptomatic COVID-19 during the first 14 months of Omicron, providing significant protection against re-infection for more than 2 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2COVID-19 VaccinesHumansOntarioFemaleMaleMiddle AgedAdultProspective StudiesAgedVaccinationYoung AdultAdolescent

Stichwörter der Autor:innen

COVID-19Re-infectionSARS-CoV-2 infectionVaccination

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Microbiology, Sinai Health, Toronto, Canada.
  • Michael Garron Hospital, Toronto East Health Network, Toronto, Canada.
  • Department of Medicine, University of Toronto, Toronto, Canada.
  • Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Canada.
  • Department of Molecular Genetics, University of Toronto, Toronto, Canada.
  • Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Förderung

  • Pfizer

Zitieren

APA

Shigayeva, A., Kandel, C., Farooqi, L., Zhong, Z., Gingras, A. C., Coleman, B. L., Gilbert, L., Gold, W. L., Major, M., Mazzulli, T., Mubareka, S., Vojicic, J., Yang, J., Zhang, P., Martin, C., Kyaw, M. H., McLaughlin, J. M., & McGeer, A. (2025). Early COVID-19 and protection from Omicron in a highly vaccinated population in Ontario, Canada: a matched prospective cohort study. BMC Infectious Diseases. https://doi.org/10.1186/s12879-024-10331-1

Vancouver

Shigayeva A, Kandel C, Farooqi L, Zhong Z, Gingras AC, Coleman BL, et al. Early COVID-19 and protection from Omicron in a highly vaccinated population in Ontario, Canada: a matched prospective cohort study. BMC Infectious Diseases. 2025. doi:10.1186/s12879-024-10331-1

BibTeX
@article{Shigayeva2025,
  author = {Shigayeva, Altynay and Kandel, Christopher and Farooqi, Lubna and Zhong, Zoe and Gingras, Anne-Claude and Coleman, Brenda L and Gilbert, Lois and Gold, Wayne L and Major, Maria and Mazzulli, Tony and Mubareka, Samira and Vojicic, Jelena and Yang, Jingyan and Zhang, Pingping and Martin, Catherine and Kyaw, Moe H and McLaughlin, John M and McGeer, Allison},
  title = {Early COVID-19 and protection from Omicron in a highly vaccinated population in Ontario, Canada: a matched prospective cohort study},
  journal = {BMC Infectious Diseases},
  year = {2025},
  doi = {10.1186/s12879-024-10331-1}
}
Kostenlos starten →